Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $4,451 - $5,794
-113 Reduced 2.21%
4,991 $203,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $11,147 - $14,551
-267 Reduced 4.97%
5,104 $261,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $12,602 - $15,384
288 Added 5.67%
5,371 $235,000
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $1,488 - $1,765
32 Added 0.63%
5,083 $267,000
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $61,076 - $75,681
1,335 Added 35.93%
5,051 $261,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $153,545 - $227,605
3,716 New
3,716 $219,000
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $342,730 - $384,807
-9,268 Closed
0 $0
Q1 2019

Apr 18, 2019

BUY
$37.5 - $41.2 $347,550 - $381,841
9,268 New
9,268 $370,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track E Rn Financial, LLC Portfolio

Follow E Rn Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Rn Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on E Rn Financial, LLC with notifications on news.